Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
43 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Duodenal Diseases" (43 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Recruiting Concomitant Therapy of H. Pylori
Condition: Gastritis, Gastric Ulcer, and Duodenal Ulcer
Intervention: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole
3 Recruiting The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: esomeprazole or pantoprazole;   Procedure: Endoscopic hemostasis
4 Not yet recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
5 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
6 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
7 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
8 Recruiting Early Selective Transarterial Embolization (TAE) to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis
Conditions: Bleeding;   Peptic Ulcer;   Arterial Embolization
Interventions: Procedure: TAE;   Procedure: No TAE
9 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention:
10 Recruiting Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study
Condition: Bleeding Peptic Ulcers
Interventions: Device: Hemospray;   Device: Combined Conventional Technique
11 Unknown  Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
Condition: Peptic Ulcer Hemorrhage
Interventions: Other: Empirical  Hp eradication;   Other: Eradication treatment guided by a positive test
12 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
Intervention:
13 Recruiting A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Pancreatitis, Chronic;   Duodenal Neoplasms
Intervention: Procedure: pancreaticojejunostomy
14 Unknown  Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
Condition: Peptic Ulcer
Intervention: Drug: esomeprazole
15 Unknown  PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
Condition: Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Famotidine
16 Recruiting Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
Conditions: Bleeding Gastric Ulcer;   Bleeding Duodenal Ulcer
Interventions: Drug: L-pantoprazole sodium;   Drug: Panmeilu
17 Recruiting Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)
Conditions: Bleeding Peptic Ulcer;   Active Bleeding;   Gastrointestinal Bleeding
Interventions: Other: Urgent endoscopy;   Other: Early endoscopy
18 Unknown  Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
Conditions: Peptic Ulcer;   Ulcer Complications
Interventions: Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
19 Recruiting Adverse Events During Upper Gastrointestinal Endoscopy
Conditions: Patients Need Upper Gastrointestinal Endoscopy;   Peptic Ulcer;   Gastric Cancer;   Esophagus Cancer;   Oesophagitis
Intervention:
20 Unknown  Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years